Sun-Young Han

Affiliations: 
2000-2005 Pharmacology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Google:
"Sun-Young Han"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ko B, Jang Y, Kim MH, et al. (2023) Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia. European Journal of Medicinal Chemistry. 262: 115860
Lee JH, Shin JE, Kim W, et al. (2022) Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia. European Journal of Medicinal Chemistry. 237: 114356
Lee HJ, Moon Y, Choi J, et al. (2022) Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects. Biomolecules & Therapeutics
Lee HJ, Jeong P, Moon Y, et al. (2021) Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharmaceuticals (Basel, Switzerland). 14
Yoon KB, Lee HJ, Chung HJ, et al. (2019) Discovery of LDD-1075 as a potent FLT3 inhibitor. Oncology Letters. 17: 4735-4741
Ndolo KM, An SJ, Park KR, et al. (2018) Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with Anti-Tumor Effects. Biomolecules & Therapeutics
Lee HJ, Lee J, Jeong P, et al. (2018) Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia. Oncotarget. 9: 924-936
Lee CS, Baek J, Han SY. (2017) The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment. Molecules (Basel, Switzerland). 22
Yoon KB, Cho SY, An SJ, et al. (2017) Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor. Oncology Letters. 14: 1347-1354
Ndolo KM, Park KR, Lee HJ, et al. (2017) Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells. Immune Network. 17: 110-115
See more...